Causal relationships between type 1 diabetes mellitus and Alzheimer’s disease and Parkinson’s disease: a bidirectional two-sample Mendelian randomization study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Causal relationships between type 1 diabetes mellitus and Alzheimer’s disease and Parkinson’s disease: a bidirectional two-sample Mendelian randomization study ; volume:29 ; number:1 ; day:16 ; month:1 ; year:2024 ; pages:1-10 ; date:12.2024
European journal of medical research ; 29, Heft 1 (16.1.2024), 1-10, 12.2024
- Creator
-
Geng, Chaofan
Meng, Ke
Zhao, Bo
Liu, Xiaoduo
Tang, Yi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40001-023-01628-z
- URN
-
urn:nbn:de:101:1-2024032722233640694834
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Geng, Chaofan
- Meng, Ke
- Zhao, Bo
- Liu, Xiaoduo
- Tang, Yi
- SpringerLink (Online service)
Other Objects (12)
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
Differentiation of neuropsychological features between posterior cortical atrophy and early onset Alzheimer’s disease
Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Measuring compounds in exhaled air to detect Alzheimer´s disease and Parkinson´s disease
Effects of gene mutation and disease progression on representative neural circuits in familial Alzheimer’s disease
SNAP25 is a potential target for early stage Alzheimer’s disease and Parkinson’s disease
Gene expression meta-analysis of Parkinson’s disease and its relationship with Alzheimer’s disease
Correction to: Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease
Role of glucagon-like peptide-1 receptor agonists in Alzheimer’s disease and Parkinson’s disease
Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
Development of seed amplificafion assays as biomarkers for Alzheimer’s & Parkinson’s disease
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
Differentiation of neuropsychological features between posterior cortical atrophy and early onset Alzheimer’s disease
Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Measuring compounds in exhaled air to detect Alzheimer´s disease and Parkinson´s disease
Effects of gene mutation and disease progression on representative neural circuits in familial Alzheimer’s disease
SNAP25 is a potential target for early stage Alzheimer’s disease and Parkinson’s disease
Gene expression meta-analysis of Parkinson’s disease and its relationship with Alzheimer’s disease
Correction to: Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease
Role of glucagon-like peptide-1 receptor agonists in Alzheimer’s disease and Parkinson’s disease
Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
Development of seed amplificafion assays as biomarkers for Alzheimer’s & Parkinson’s disease
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
Differentiation of neuropsychological features between posterior cortical atrophy and early onset Alzheimer’s disease
Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Measuring compounds in exhaled air to detect Alzheimer´s disease and Parkinson´s disease
Effects of gene mutation and disease progression on representative neural circuits in familial Alzheimer’s disease
SNAP25 is a potential target for early stage Alzheimer’s disease and Parkinson’s disease
Gene expression meta-analysis of Parkinson’s disease and its relationship with Alzheimer’s disease
Correction to: Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease
Role of glucagon-like peptide-1 receptor agonists in Alzheimer’s disease and Parkinson’s disease
Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia